03 Profile
Hansard to 9 November 2026 · 31,243 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Heart disease & stroke
Laura Marcu
Founding director of NCIBT; Endowed Professor in Neurosurgical Research; professor in Neurological Surgery and Biomedical Engineering, UC Davis
press citation on 1 topic since 21 Oct 2026 · last quoted 21 Oct 2026
02 Quoted on · 1 of 29 topics
Laura Marcu: key facts
- Kind of voice
- Academic
- Role
- Founding director of NCIBT; Endowed Professor in Neurosurgical Research; professor in Neurological Surgery and Biomedical Engineering, UC Davis
- Quoted on
- Heart disease & stroke
- Tracked press citations
- 1
- Most recently quoted
- 21 Oct 2026
04 The signal · where Laura Marcu sits on heart disease & stroke
Ranked 45= of 100 voices quoted in the press on heart disease & stroke, level with 55 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Dr Sonya Babu-NarayanClinicianClinical Director, British Heart Foundation7 - 2=
Professor Azeem MajeedAcademicProfessor of Primary Care and Public Health and Head of the Department of Primary Care and Public Health, Imperial College London6 - 2=
Professor Bryan WilliamsSector leaderChief Scientific and Medical Officer, British Heart Foundation (BHF)6 - 45=Gari CliffordAcademican author of the study from Emory University1
- 45=Jeffrey SouthardAcademicUC Davis interventional cardiologist1
- 45=Laura MarcuAcademicFounding director of NCIBT; Endowed Professor in Neurosurgical Research; professor in Neurological Surgery and Biomedical Engineering, UC Davis1
- 45=Patrick DonnellyClinicianProf, Consultant Cardiologist and NI cardiac rehabilitation and prevention lead1
Showing the leaders and the ranks around 45=, of 100 voices · See every voice on the topic →
05 On the record · press
What Laura Marcu has said
- medicalxpress.com1
Where Laura Marcu has been quoted
- 01First-in-human study of dual-imaging catheter to assess heart attack risk, guide treatmentmedicalxpress.com · 21 Oct 2026
Verbatim
“Testing this device marks a major step toward advancing heart health. Our technology could help clinicians better understand atherosclerotic cardiovascular disease progression and personalize treatment.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.